Zimmer Biomet Holdings Stock-Based Comp increased by 0.4% to $24.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.5%, from $19.60M to $24.20M. Over 4 years (FY 2021 to FY 2025), Stock-Based Comp shows an upward trend with a 4.4% CAGR.
Increasing levels may indicate a focus on talent retention but can also signal potential shareholder dilution.
This represents the value of equity-based awards granted to employees as part of their total compensation package. Since...
Standard across large-cap corporations; varies based on corporate compensation philosophy.
stock_based_compensation| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $22.30M | $18.70M | $14.90M | $23.20M | $27.60M | $27.40M | $26.80M | $25.00M | $33.90M | $15.60M | $25.30M | $29.00M | $26.40M | $24.50M | $21.10M | $19.60M | $21.20M | $25.30M | $24.10M | $24.20M |
| QoQ Change | — | -16.1% | -20.3% | +55.7% | +19.0% | -0.7% | -2.2% | -6.7% | +35.6% | -54.0% | +62.2% | +14.6% | -9.0% | -7.2% | -13.9% | -7.1% | +8.2% | +19.3% | -4.7% | +0.4% |
| YoY Change | — | — | — | — | +23.8% | +46.5% | +79.9% | +7.8% | +22.8% | -43.1% | -5.6% | +16.0% | -22.1% | +57.1% | -16.6% | -32.4% | -19.7% | +3.3% | +14.2% | +23.5% |